Concepedia

Prabhavathi Fernandes

PF

77

Publications

4.5K

Citations

40

H-Index

1977

Active since

Affiliations

Cempra Pharmaceuticals (United States)(Current)

Abbott Fund

Abbott (United Kingdom)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Prabhavathi Fernandes is an author at Cempra Pharmaceuticals (United States) specializing in medicine, pharmacology, and antimicrobial resistance.

ORCID

Top concepts

Publications per year

1977–2019

77

Publications

77

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

Dwight J. Hardy, Dena M. Hensey, Jill Beyer et al. · Antimicrobial Agents and Chemotherapy · 1988 · 302 citations

, , +20

Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y Receptor

Patricia M. Rose, Prabhavathi Fernandes, Jean S. Lynch et al. · Journal of Biological Chemistry · 1995 · 263 citations · Full text

Antibacterial discovery and development—the failure of success?

Prabhavathi Fernandes · Nature Biotechnology · 2006 · 245 citations

, , +9

Bacillaene, a Novel Inhibitor of Procaryotic Protein Synthesis Produced by Bacillus subtilis: Production, Taxonomy, Isolation, Physico-chemical Characterization and Biological Activity.

Pramathesh S. Patel, Stella Huang, S L Fisher et al. · The Journal of Antibiotics · 1995 · 203 citations · Full text

In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide

Prabhavathi Fernandes, Robert T. Bailer, R. N. Swanson et al. · Antimicrobial Agents and Chemotherapy · 1986 · 162 citations

, , +17

Rows per page

1–5 of 77